| COVID-19 |
1 |
1 |
| Cognitive Impairment |
0 |
0.99 |
| Impairment |
0 |
0.64 |
| Severe Acute Respiratory Syndrome |
0 |
0.48 |
| Acute Respiratory Distress Syndrome |
0 |
0.45 |
| Mild Cognitive Impairment |
0 |
0.3 |
| Anxiety |
0 |
0.16 |
| Cognitive Deficits |
0 |
0.16 |
| Memory |
0 |
0.16 |
| Pain |
0 |
0.16 |
| Peer Review |
0 |
0.16 |
| Triage |
0 |
0.16 |
| Anxiety Disorder |
0 |
0.15 |
| Depression |
0 |
0.15 |
| Pain Management |
0 |
0.15 |
| Canada |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Delirium |
0 |
0.08 |
| Disability |
0 |
0.08 |
| Encephalitis |
0 |
0.08 |
| Fatigue |
0 |
0.08 |
| Florida |
0 |
0.08 |
| Generics |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Hospital |
0 |
0.08 |
| Literacy |
0 |
0.08 |
| Polymerase Chain Reaction |
0 |
0.08 |
| Preventive Screening |
0 |
0.98 |
| Receptors |
0 |
0.08 |
| Seizure |
0 |
0.08 |
| Sleep |
0 |
0.08 |
| Cerebrovascular Accident |
0 |
0.07 |
| Sleep Disorders |
0 |
0.07 |
| Telehealth and Telemedicine |
0 |
0.07 |